We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > GPCR

News List

Confo Therapeutics Forms Scientific Advisory Board as It Accelerates Development of Proprietary Drug Discovery Engine pharmaasia
March 01, 2019
Confo Therapeutics, an emerging drug discovery company, today announces the formation of its Scientific Advisory Board (SAB) with four key appointments: Radu Aricescu, Peter Kolb, Graeme Milligan and Jan Steyaert, Founder of Confo Therapeutics, who will s
Boehringer inks pact with Domain for GPCR neurology drugs fiercebiotech
January 02, 2019
French-Canadian biotech Domain Therapeutics has another big pharma partner, signing a deal with Germany’s Boehringer Ingelheim to develop new drugs for central nervous system (CNS) disorders....

Previous page 1 2 Next page